Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection

S. E. M. Howie, P. J. Horner, A. W. Horne, Gary Entrican

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose of review The aim is to review recent findings on immunity and vaccine development to Chlamydia trachomatis.

Recent findings There is increasing knowledge on the interactions between C. trachomatis and infected host cells. During genital infection the organism avoids generating protective immunity but immune responses to a number of chlamydial proteins have been associated with reproductive tract pathology. Various vaccine and adjuvant preparations have been tried experimentally. Information generated by proteomics and complex studies of serological and T-lymphocyte immune responses points to novel vaccine candidates.

Summary C. trachomatis, an obligate intracellular bacterium, is the commonest sexually transmitted infection worldwide and is associated with reproductive pathology. To develop rational vaccines it is necessary to understand the complex lifecycle of the organism, the host immune response to infection and how these relate to disease. Infection does not prevent re-infection and antibiotic treatment prevents antibody production at a population level. It remains unclear what type of immune response would be sufficient to prevent infection and/or re-infection. Although the prevalence and demographics of infection and the severity of disease associations suggest that it would be desirable, there is no vaccine currently available. A number of studies have identified novel vaccine candidates.
Original languageEnglish
Pages (from-to)56-61
Number of pages6
JournalCurrent Opinion in Infectious Diseases
Volume24
Issue number1
DOIs
Publication statusPublished - Feb 2011

Keywords

  • Adjuvants, Immunologic
  • Bacterial Vaccines
  • Chlamydia trachomatis
  • Host-Pathogen Interactions
  • Humans
  • Lymphogranuloma Venereum

Fingerprint

Dive into the research topics of 'Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection'. Together they form a unique fingerprint.

Cite this